Turing Pharmaceuticals, under fire for raising the price of a drug used by cancer and AIDS patients by 5,000 percent, on Tuesday said it would offer its Daraprim medication to hospitals at what it called a "significant" price cut.
The Swiss company will slash the list price for Daraprim by as much as 50 percent and plans to make smaller bottles of the drug available starting next year to make it more affordable to stock. In addition, Turing will offer sample starter packages at no cost so physicians can start treatment immedi...
14:53 Netflix fueled by original programming, even as its costs hold earnings back, analysts say14
06:13 Pound quivers near three-month low, stocks weak before May's Brexit stance speech19
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant18
05:09 Sterling slides to 3-month lows on 'hard Brexit' fears13